Knowing about recent IPOs is a great way to stay up to date on the IPO market. Initial public offerings can often provide great investment opportunities – but they don’t always. Below is a short list of some of the top recent IPOs by month.

To make it easier for you, we’ve provided comprehensive information about each recent IPO. First, you can learn about the company’s purpose and mission. Then, you’ll find a summary of the company’s recent financial information. Finally, you’ll be provided with a summary of the recent IPO filing details.

Top Recent IPOs: April

top recent IPOs April

Ostin Technology Group (OST)

Ostin Technology Group is a Chinese supplier of display modules and polarizers. The company designs, develops and manufactures TFT-LCD modules in a range of sizes and customized sizes. Its display modules are mainly used in consumer electronics, outdoor LCD displays and automotive displays. Moreover, the company also manufactures polarizers for TFT-LCD display modules. It’s in the process of developing polarizers for OLED display panels.

Ostin Technology Group’s revenue as of September 30, 2020 was $140 million. However, by September 2021, the company’s revenue grew to $167.7 million – representing year-over-year growth of nearly 20%. For the same period, gross profit stood at $11.6 million and $17.4 million, respectively. The company recorded $2.8 million in net income for the 2020 year. However, at the end of its 2021 fiscal year, net income rose to $3.3 million.

The company filed March 5 and priced on April 26. It issued 3.4 million shares under the ticker symbol OST. The company priced at $4 per share. A $14 million profit came from the offering. As a result, the company’s market cap is $28.6 million.

You can look at Ostin Technology Group’s prospectus here.

First Day Return: 891.5%

Genius Group (GNS)

Genius Group provides online and in-person education services. The company has around 1.8 million students in 200 countries, ranging from ages 0 to 100. Its mission is to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today’s market. Genius Group has over 2,500 teachers and over 8,000 partners globally.

Genius Group’s recorded assets stand at $78.8 million as of June 30, 2021. Its total liabilities were recorded at $41.2 million as of July 30, 2021. For the six months ended June 30, 2021, the company recorded $2.1 million in gross profit. Moreover, the company recorded total income at $1.2 million for the same period.

Genius Group filed on July 6 and priced on April 11. Shares listed under the ticker GNS on the New York Stock Exchange (NYSE). The company priced at the top of its $5 to $6 range at $6 per share. In addition, the company offered 3.3 million shares of common stock for a $20 million offering. As a result, Genius Group has a $125.2 million market cap.

You can look at Genius Group’s prospectus here.

First Day Return: 408.3%

JE Cleantech Holdings (JCSE)

JE Cleantech Holdings makes cleaning equipment and provides dishwashing and cleaning services in Singapore. The company primarily operates in Singapore in food courts, hawker centers, restaurants, cookhouses and eldercare homes. JE Cleantech Holdings is also an inflight catering service provider. Its mission is to be an industry leader in the cleaning systems. The company is also on a mission to be a leader in the design, development and manufacturing of the precision cleaning systems industry.

JE Cleantech Holdings recorded $15.9 million in revenue for the year ended December 2020 and $6.6 million for the period ended June 2021. As of June 2021, JE Cleantech Holdings recorded $13.4 million in total assets. For the same period, the company recorded $9.1 million in total liabilities. Moreover, the company recorded net income of $456,000 for the period ended June 2021.

JE Cleantech Holdings filed on March 10 and priced on April 21. Shares listed under the ticker JCSE on the Nasdaq exchange. The offering consisted of 3.8 million shares. The company priced at $4 per share for a $15 million deal. The JE Cleantech Holdings IPO gave the company a market cap of almost $154 million.

You can look at JE Cleantech Holdings’ prospectus here.

First Day Return: 375.0%

Tenon Medical (TNON)

Tenon Medical is launching a surgical implant system for sacroiliac joint fusion procedures. The company has developed a proprietary, FDA cleared surgical implant system, which is designed to optimize sacroiliac joint (SI-Joint) fixation / fusion surgery. Tenon is preparing a national launch of this system to address an underserved market opportunity in this space.

Tenon Medical’s revenue for fiscal 2020 and 2021 was $43,820 and $159,800. Total assets stood at $390,901 for the year ended December 2020 and $9.3 million for the year ended December 2021. Moreover, for the same period, Tenon Medical recorded total liabilities at $1.8 million and $16.2 million. The company recorded $705,365 in net losses for the year ended December 2020. By December 2021, net losses grew to $7.1 million.

Tenon Medical filed on November 10 and set its terms on April 26. Shares listed under the ticker TNON on the Nasdaq exchange. The offering consisted of 3.2 million shares priced at $5 per share of common stock. This was at the midpoint of the company’s proposed $4.50 to $5.50 price range. The company raised $16 million in its initial public offering. As a result, Tenon Medical has a market cap of $99.6 million.

You can look at Tenon Medical’s prospectus here.

First Day Return: 350.0%

Belite Bio (BLTE)

Belite Bio is a phase 2/3 biotech developing an oral therapy for retinal degeneration diseases. The company is focused on novel therapeutics targeting currently untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration (commonly known as dry AMD). It’s also focused on autosomal recessive Stargardt disease, or STGD1. These conditions both progressively lead to permanent blindness. Furthermore, the company is developing therapies for metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH) and type 2 diabetes (T2D).

For the 2020 fiscal year, Belite Bio recorded $5.8 million in net losses. In 2020, net losses grew to $9.8 million. The company recorded $25.6 million in cash as of December 2020. By the end of 2021, Belite Bio’s recorded cash decreased to $17.3 million. As of December 2021, the company has $18.3 million in total assets and $1.6 million in total liabilities.

Belite Bio filed on April 5 and priced on April 29. Shares listed under the ticker BLTE on the Nasdaq exchange. Shares priced at the midpoint of its $5.50 to $6.50 range at $6 per share of common stock. The company offered $6 million shares for a $36 million offering. As a result, Belite Bio has a market cap of $328.7 million.

You can look at Belite Bio’s prospectus here

First Day Return: 76.5%

Top Recent IPOs: March

Top Recent IPOs march

Note: Only two IPOs took place in the month of March.

Akanda (AKAN)

Akanda is a cannabis cultivation, manufacturing and distribution company. It’s on a mission to provide premium quality medical cannabis products to patients worldwide. To do this, the company c​​ultivates and processes natural cannabis at its facilities in the Kingdom of Lesotho, Africa. The company supplies its medicinal-grade cannabis biomass, cannabis flower and cannabis concentrates to wholesalers in international markets.

Akanda started in July 2021. Net losses from inception to August 2021 stood at $31,900. For the same period, the company recorded $250,000 in cash. The company acquired Bophelo and CanMart in November 2021. In total, the companies have $14.7 million in debt as of September 2021. Moreover, cash and cash equivalents stand at $960,000 for the same period.

The company filed January 31 and priced on March 14. It issued 4 million shares under the ticker symbol AKAN. The company priced at $4 per share. A $16 million profit came from the offering. As a result, the company’s market cap is $285.3 million.

You can look at Akanda’s prospectus here.

First Day Return: 162.5%

AN2 Therapeutics (ANTX)

AN2 Therapeutics is a clinical-stage biopharmaceutical company. It focuses on treatments for rare, chronic and serious infectious diseases with high unmet needs. The company’s main product candidate is Epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or lung disease. Moreover, AN2 is in arrangements to conduct its Phase 2/3 clinical trial in treatment-refractory Mycobacterium avium complex, or MAC, lung disease, which is the most common type of NTM lung disease.

AN2 Therapeutics’ recorded total assets for 2020 and 2021 stood at $4.1 million and $12.1 million, respectfully. For the same period, the company recorded $1.5 million and $3.4 million in total liabilities. Net losses were $13.6 million in 2020 and $21.5 million in 2021. The company recorded no cash as of December 2020. However, by the end of 2021, cash stood at $8.1 million.

AN2 Therapeutics filed on March 4 and priced on March 24. Shares listed under the ticker ANTX on the Nasdaq exchange. The company priced at the midpoint of its $14 to $16 range att $15 per share. The company offered 4.6 million shares of common stock for a $69 million offering. As a result, AN2 Therapeutics has a $262.7 million market cap.

You can look at AN2 Therapeutics’ prospectus here.

First Day Return: 2.7%

Top Recent IPOs: February

Top recent IPOs February

Blue Water Vaccines (BWV)

Blue Water Vaccines is a preclinical biotech company. It focuses on developing vaccines for the flu and other infectious diseases. Moreover, Blue Water Vaccines has a lead influenza (flu) vaccine program that identifies specific epitopes, or proteins, with cross-reactive properties. As a result, the company is able to develop potential universal flu vaccines. The company focuses on developing durable and long-term immunity through its vaccines.

Blue Water Vaccines’ total assets as of December 31, 2019 stood at $6.1 million. By September 2021, the company’s total assets stood at $3.4 million – representing year-over-year losses of 44%. For the same period, total liabilities were $82,600 and $796,000. The company recorded $1.6 million in net losses in 2020. For the nine months ended September 2021, net losses grew to $2.2 million.

The company filed October 10 and priced on February 17. It issued 2.2 million shares under the ticker symbol BWV. The company priced at the midpoint of its $8 to $10 range at $9 per share. A $20 million profit came from the offering. As a result, the company’s market cap is around $600 million.

You can look at Blue Water Vaccines’ prospectus here.

First Day Return: 537.8%

Meihua International (MHUA)

Meihua International is a Chinese manufacturer of disposable medical products. The company provides Class I, II and III disposable medical services. In addition, Meihua International has operating subsidiaries in China. The company serves hospitals, pharmacies, medical institutions and medical equipment companies. Furthermore, the company offers over 800 products for domestic sales and 120 products for exports.

Meihua International’s recorded revenue for the fiscal year ended December 2019 and December 2020 was $79.6 million and $89 million – representing year-over-year growth of nearly 12%. Net income was $15.4 million and $19 million for the year ended December 2019 and December 2020. The company recorded $32.2 million in gross profit in December 2019. A year later, gross profit grew to $37.1 million.

Meihua International filed on August 10 and priced on February 15. Shares listed under the ticker MHUA on the Nasdaq exchange. The company priced at the midpoint of its $9 to $11 range at $10 per share. The company offered 3.6 million shares of common stock for a $36 million offering. As a result, Bionomics has close to a $200 million market cap.

You can look at Meihua International’s prospectus here.

First Day Return: 29.2%

Arcellx (ACLX)

Arcellx is a Phase 1 biotech company. The company specializes in innovative immunotherapies for patients with relapsed or refractory multiple myeloma. It is developing next-gen CAR-T therapies for blood cancers. Moreover, the company recently announced positive preliminary results from its Phase 1 clinical trial of CART-ddBCMA, Arcellx’s lead ddCAR product candidate.

Arcellx recorded $23 million in operating losses for the nine months ended April 2020 and $44.3 million for the same period in 2021. As of September 30, 2021, Arcellx recorded $70 million in cash. For the same period in 2021, the company recorded $145 million in total assets and $15.4 million in total liabilities.

Arcellx filed on January 14 and priced on February 3. Shares listed under the ticker ACLX on the Nasdaq exchange. The offering consisted of 8.3 million shares. The company priced at the low end of its expected $15 to $17 range for a $124 million deal. As a result, the Arcellx IPO gave the company a market cap of almost $600 million.

You can look at Arcellx’s prospectus here.

First Day Return: 12%

The Arena Group (AREN)

The Arena Group is a media holding company. It operates Sports Illustrated, TheStreet and other brands. The company’s focus is on leveraging its platform and other brands to maximize the audience, improve engagement and optimize monetization of digital publishing assets. To date, the company operates and owns 35 properties. In addition, the company powers over 200 independent publisher partners.

The Arena Group’s revenue for fiscal 2020 and 2021 was $128 million and $185 million. Total assets stood at $214.2 million as of December 2020 and $190.2 million as of September 2021. Moreover, for the same period, The Arena Group recorded total liabilities at $216.1 million and $219.5 million. The company recorded $8.9 million in cash in December 2020. By December 2021, cash grew to $9 million.

The Arena Group filed on January 12 and set its terms on February 11. Shares listed under the ticker AREN on the New York Stock Exchange. The offering consisted of 3.6 million shares priced at $8.25 per share of common stock. This was below the company’s proposed $12.65 price range. The company raised $30 million in its initial public offering. As a result, The Arena Group has a market cap of $130 million.

You can look at The Arena Group’s prospectus here.

First Day Return: 0%

HeartCore Enterprises (HTCR)

HeartCore Enterprises is a Japanese provider of customer experience software and information technology services. Its customer experience management platform (CXM Platform) includes marketing, sales, service and content management systems to help companies attract and engage customers. In addition, HeartCore’s second business is a digital transformation business that provides customers with robotics process automation, process mining and task mining.

For the 2019 fiscal year, HeartCore Enterprises recorded $7.2 million in total revenue. In 2020, total revenue grew to $9 million. The company recorded $1.3 million in net losses for 2019. However, net income rose to $155,100 in 2020. As of September 2021, HeartCore Enterprises has $3.1 million in cash.

HeartCore Enterprises filed on January 3 and priced on February 9. Shares listed under the ticker HTCR on the Nasdaq exchange. Shares priced at the midpoint of its $4 to $6 range at $5 per share of common stock. The company offered $3 million shares for a $15 million offering. As a result, HeartCore Enterprises has a market cap of close to $40 million.

You can look at HeartCore Enterprises’ prospectus here

First Day Return: -1%

Top Recent IPOs: January

Top Recent IPO January

Yoshitsu (TKLF)

Yoshitsu is a Japanese retailer and wholesaler of beauty, health and other products. The Tokyo-based company offers 12,400 SKUs of beauty products and 3,600 SKUs of health products. Its beauty-based products include cosmetics, skincare, fragrance and body care. In addition, the company’s health products include OTC drugs, nutritional supplements, and medical supplies and devices. Furthermore, Yoshitsu offers other products, including home goods, food and alcoholic drinks.

Yoshitsu’s revenue for the fiscal 2020 and 2021 was $139.6 million and $221.5 million – representing year-over-year growth of 59%. Operating expenses were $130.2 million and $210.9 million for fiscal 2020 and 2021. The company recorded $4.9 million in net income in 2020. A year later, net income grew to $5.5 million.

The company filed August 27 and priced on January 7. It issued 6 million shares under the ticker symbol TKLF. The company priced at the low end of its $4 to $6 range at $4 per share. A $24 million profit came from the offering. As a result, the company’s market cap is $128.5 million.

You can look at Yoshitsu’s prospectus here.

First Day Return: 700%

Hour Loop (HOUR)

Hour Loop is an online retailer that sells various household goods primarily on Amazon. Additionally, it sells products on its website and Walmart. Its product line contains over 100,000 products. Furthermore, Hour Loop’s product categories include home and garden decor, toys, kitchenware, apparel and electronics.

Hour Loop’s recorded revenue for the nine months ended September 2020 and September 2021 was $17.5 million and $31.4 million – representing year-over-year growth of 79%. Net losses were $1.2 million and $2.3 million for the nine months ended September 2020 and September 2021. The company recorded $1.2 million in cash in September 2020. A year later, cash grew to $4.5 million.

Hour Loop filed on October 28 and priced on January 6. Shares listed under the ticker HOUR on the Nasdaq exchange. The company priced at $4 per share. The company offered 1.5 million shares of common stock for a $6 million offering. As a result, Bionomics has a $98.8 million market cap.

You can look at Hour Loop’s prospectus here.

First Day Return: 99.8%

Credo Technology (CRDO)

Credo Technology provides semiconductor solutions. It offers connectivity solutions optimized for optical and electrical Ethernet applications. In addition, it offers products based on its Serializer/Deserializer (SerDes) and Digital Signal Processor (DSP) technologies.

Credo Technology recorded $53.8 million in total revenue for the year ended April 2020 and $58.7 million for the year ended April 2021. Furthermore, for the year ended April 2020, Credo Technology recorded $1.3 million in net income. However, for the same period in 2021, the company recorded $27.5 million in net losses.

Credo Technology filed on January 3 and priced on January 26. Shares listed under the ticker CRDO on the Nasdaq exchange. The offering consisted of 20 million shares. The company priced at the top end of its expected $10 to $12 range for a $200 million deal. As a result, the Credo Technology IPO gave the company a market cap of almost $1.8 billion.

You can look at Credo Technology’s prospectus here.

First Day Return: 16.5%

TPG (TPG)

TPG is a global alternative asset manager. The company primarily invests in non-traditional, complex asset classes. This includes private equity, real estate and public market strategies. Furthermore, the company has constructed a base of assets over five investment platforms: capital, growth, impact, real estate and market solutions.

TPG’s revenue for the nine months ended September 2020 and September 2021 was $564.4 million and $3.9 billion. Furthermore, Net income was $295.2 million and $3.8 billion for the nine months ended September 2020 and September 2021. The company recorded $858.2 million in cash in December 2020. By September 2021, cash grew to $1.8 billion.

TPG filed on December 16 and set its terms on January 12. Shares listed under the ticker TPG on the Nasdaq exchange. The offering consisted of 33.9 million shares priced at $29.5 per share of common stock. Moreover, this was at the midpoint of the company’s proposed $28 to $31 price range. The company raised $1 billion in its initial public offering. As a result, TPG has a market cap of $2.3 billion.

You can look at TPG’s prospectus here.

First Day Return: 15.3%

The Bottom Line on Recent IPOs

Getting well-versed on recent IPOs can help you understand market trends and learn more about companies going public. However, make sure to do your research before investing. As always, returns are never guaranteed with investing. So, this is where a deep dive into a company and its finances can make all the difference.

Moreover, check out our IPO calendar for the latest IPO news. We update it daily to give you the latest news on upcoming and filed IPOs.